Moreover, following positive results in patients with a connective tissue disease, rheumatologists often repeat ANA testing unnecessarily, and as a result, the American College of Rheumatology and British Society for Rheumatology also are against repeating ANA testing unless the disease picture has changed [12,13]. This evidence concerns the gene BTG3 and connective tissue disorder.